Investors Ki Lottery, Company Pe Pressure?
Turtlemint ka IPO ka structure hi aisa hai ki purane investors ko bahar nikalne ka full fayda mil raha hai. Isme 28.6 million shares ka 'Offer for Sale' (OFS) hai, matlab existing shareholders apna maal bech rahe hain. Naye paisa sirf around ₹6,607 million hi judega. Promoter log bhi 4.3 million shares bech rahe hain. Isse Peak XV Partners, Nexus Venture Partners, Jungle Ventures, Blume Ventures, aur CRED ke Kunal Shah jaise bade investors ko fayda hoga. Ye log jab investment kiye the tab valuation kam tha, ab estimated 12-14 times tak ka profit bana sakte hain. Total shares worth ₹5,000 crore se zyada bikne ka chance hai. Matlab, company ko growth ke liye paisa kam, investors ko liquidity dene pe zyada focus hai.
Valuation High, Losses Bhi High
Turtlemint ka target hai IPO mein $1.3–1.5 billion ka valuation, jo 2022 ke $900 million se kaafi zyada hai. Lekin asliyat mein, company ka loss badh raha hai. FY26 ke pehle half (H1 FY26) mein net loss 26% badh kar ₹125 crore ho gaya hai. FY25 mein revenue ₹662.7 crore tak pahuncha tha, jo FY24 ke ₹505.05 crore se zyada hai. Par company hamesha se hi profit mein aane ke liye struggle kar rahi hai. Net worth kam hui hai aur operations se cash flow negative hai. Market ab sirf growth nahi, profit banane wali companies ko zyada pasand kar raha hai.
Rules Badle, Revenue Streams Bhi
IRDAI ke 2023 Expense of Management (EOM) rules ne Turtlemint ka revenue model hi change kar diya. Pehle jo insurers marketing fee dete the, wo ab 81% se bhi zyada gir gaya hai FY24 mein, aur ab income ka sirf 7.13% hai. FY25 mein jo revenue growth dikh raha hai, wo mainly TIB (Turtlemint Insurance Broking Services Pvt Ltd) ke acquisition ki wajah se hai. Pro forma basis pe dekha jaaye toh 24% year-on-year growth hai. Lekin yeh growth asli (organic) nahi hai aur purane numbers se compare karna mushkil hai.
Market Mein Competition Aur Trends
India ka insurtech market $15.8 billion se zyada ka hai aur 2030 tak 28.79% se 55.4% CAGR se grow karne ka estimate hai. Lekin ab investors ussi company mein paisa laga rahe hain jinka profit ka path clear ho. Turtlemint ki financial situation abhi waisi nahi hai. PB Fintech (Policybazaar) jaisi companies achha perform kar rahi hain, jinone Q3 FY26 mein ₹1,711 crore revenue aur profit mein achha rise dikhaya hai. Sabhi companies IRDAI ke EOM rules follow kar rahi hain.
Risks Bhi Kam Nahi
Turtlemint ki revenue mostly commission par depend karti hai, jo pehle 90-95% thi. Expenses mein sabse zyada partner acquisition cost hai, jo FY25 mein total expenses ka 76% tha. General insurance se 92.46% revenue aata hai, aur top 10 insurers se 74.51%. Ek bada threat hai 'Bima Sugam', IRDAI ka naya platform, jo intermediary commissions ko kam kar sakta hai. Iss platform par insurers zero-commission products bhi de sakte hain, jisse Turtlemint ka core revenue model change ho sakta hai. TIB ke acquisition se revenue toh badh gaya, par organic growth ka pata nahi chal raha.
IPO Ka Paisa Aur Future Strategy
IPO se jo paisa milega, use technology, employees, marketing, TIB ke working capital aur future acquisitions ke liye use kiya jayega. Company 'Beyond Top 30' (B30+) markets par focus kar rahi hai jahan unka digital partners ka network strong hai. India mein insurtech ki potential toh bahut hai, lekin Turtlemint ke liye sustainable profit banana ek bada challenge hai. Investors ka bharosa tabhi banega jab company regulatory hurdles paar kare, revenue diversify kare aur organic growth dikhaye.